Advisory Board in Hong Kong

Homozygous Familial Hypercholesterolemia (HoFH) is a rare life-threatening genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C) in the blood and premature and progressive cardiovascular disease.
FarmaMondo was pleased to host a successful advisory board on HoFH in Hong Kong a few days ago. The discussions between 7 local experts and international speakers were very fruitful and insightful. They will give us a clearer vision of how best to support patients with HoFH.
As a next step, we will build on the experts’ advice to improve diagnosis and unlock access to an advanced treatment option for patients with LDL-C in Hong Kong.